EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A core–shell microneedle system for stable fibroblast delivery in cell-based therapies

Federica Medico, Seungcheol Kim, Sachin S Surwase, Haoyan Liu, Yeu-Chun Kim

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-024-01759-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Federica Medico und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea. Hauptthemen laut MEDLINE: Fibroblasts, Needles, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Advanced Institute of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human cells, such as fibroblasts and particularly human mesenchymal stem cells (hMSCs), represent a promising and effective therapeutic tool for a range of cell-based therapies used to treat various diseases. The effective delivery of therapeutic cells remains a challenge due to limitations in targeting, invasiveness, and cell viability. To address these challenges, we developed a microneedle (MN) system for minimally invasive cell delivery with high cellular stability. The MN system comprises a core of gelatin methacryloyl (GelMA) hydrogel embedded with fibroblasts, encased in a polylactic-co-glycolic acid (PLGA) shell that enhances structural integrity for efficient skin penetration. The fabrication process involves UV-crosslinking of the GelMA hydrogel with cells, optimizing both cell encapsulation and structural strength. This MN system achieves over 80% cell viability after seven days in vitro, with the conventional GelMA formulation providing superior stability and cellular outcomes. This platform’s ability to ensure sustained cell viability presents promising implications for future applications in regenerative medicine, wound healing, and localized treatments for skin conditions. This MN system opens new avenues for cell-based therapies, offering a versatile and scalable solution for therapeutic cell delivery. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsNeedlesCell- and Tissue-Based TherapyHumansGelatinPolylactic Acid-Polyglycolic Acid CopolymerCell SurvivalHydrogelsMethacrylatesMesenchymal Stem CellsAnimalsCells, CulturedPolyglycolic AcidLactic Acid

Stichwörter der Autor:innen

Cell deliveryCore-shell structureFibroblastsGelMAMicroneedlePLGA

Substanzen

GelatinPolylactic Acid-Polyglycolic Acid CopolymerHydrogelsMethacrylatesgelatin methacryloylPolyglycolic AcidLactic Acid

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
  • Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21287, USA.
  • Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea. dohnanyi@kaist.ac.kr.

Förderung

  • Korea Advanced Institute of Science and Technology

Zitieren

APA

Medico, F., Kim, S., Surwase, S. S., Liu, H., & Kim, Y. C. (2025). A core–shell microneedle system for stable fibroblast delivery in cell-based therapies. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01759-8

Vancouver

Medico F, Kim S, Surwase SS, Liu H, Kim YC. A core–shell microneedle system for stable fibroblast delivery in cell-based therapies. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01759-8

BibTeX
@article{Medico2025,
  author = {Medico, Federica and Kim, Seungcheol and Surwase, Sachin S and Liu, Haoyan and Kim, Yeu-Chun},
  title = {A core–shell microneedle system for stable fibroblast delivery in cell-based therapies},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-024-01759-8}
}
Kostenlos starten →